41
Participants
Start Date
January 3, 2023
Primary Completion Date
December 6, 2025
Study Completion Date
December 6, 2025
PF-08046049
Given into the vein (IV; intravenous)
Ambulatory Care Center at NYU Langone Medical Center, New York
Laura & Isaac Perlmutter Cancer Center at NYU Langone Health, New York
NYU Langone Hospitals, NYU Langone Rusk Ambulatory Surgical Pharmacy, New York
NYU Langone Medical Center(Tisch Hospital), New York
Clinical Research Center Dermatology (CRCD) Dermatoonkologie Charité - Universitätsmedizin Berlin, Berlin
Clinical Research Center Dermatology (CRCD) Dermatoonkologie Charité - Universitätsmedizin Berlin, Berlin
Northwestern Medical Group, Chicago
Northwestern Memorial Hospital, Chicago
US Oncology Investigational Products Center (IPC), Irving
Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas
Texas Oncology - Baylor Sammons Cancer Center, Dallas
Quest Diagnostics Incorporated - Denver, Denver
Presbyterian/St. Lukes Medical Center, Denver
UCLA Hematology/Oncology - Administrative Office, Los Angeles
The Angeles Clinic and Research Institue, A Cedars-Sinai Affiliate, Los Angeles
Cedars-Sinai Medical Center, Los Angeles
Ronald Reagan UCLA Medical Center, Drug Information Center, Los Angeles
UCLA Hematology/Oncology, Los Angeles
The Angeles Clinic and Research Institute, A Cedars-Sinai Affiliate (Emergency Back-up only), Santa Monica
UCLA Hematology/ Oncology- Pasadena, Pasadena
UCLA Hematology - Oncology Clinic - Westlake Village, Westlake Village
UCLA Hematology/Oncology - Santa Barbara, Santa Barbara
UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco
UCSF Medical Center, Investigational Pharmacy, San Francisco
Insitut Gustave Roussy, Villejuif
Institut Gustave Roussy, Villejuif
Fred Hutchinson Cancer Center, Seattle
University of Washington Medical Center, Seattle
BWH, Boston
Dana-Farber Cancer Institute (DFCI), Boston
Laboratory Corporation of America, Raritan
The Ottawa Hospital Cancer Centre, Ottawa
Princess Margaret Cancer Centre, Toronto
Jewish General Hospital, Montreal
UniversitätsSpital Zürich Dermatologische Klinik, Zurich
The Beatson West of Scotland Cancer Centre, Glasgow
Seagen, a wholly owned subsidiary of Pfizer
INDUSTRY